Literature DB >> 1566853

Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release.

J R Grider1, K S Murthy, J G Jin, G M Makhlouf.   

Abstract

The source of nitric oxide (NO) and its role in neurally induced relaxation was examined in smooth muscle of the stomach and tenia coli. Field stimulation of gastric muscle strips was accompanied by frequency-dependent relaxation, vasoactive intestinal peptide (VIP) release, and NO production: the NO synthase inhibitor, NG-nitro-L-arginine (L-NNA) completely inhibited NO production and partly inhibited VIP release (52-54%) and relaxation (58-88%); inhibition of all three functions was reversed by L-arginine but not by D-arginine. In isolated gastric muscle cells, VIP caused relaxation and stimulated NO production: L-NNA completely inhibited NO production and partly inhibited relaxation; the inhibition was reversed by L-arginine but not by D-arginine. Abolition of NO production with only partial inhibition of relaxation implied that NO production from muscle cells induced by the action of VIP was partly responsible for relaxation. By contrast, field stimulation of tenia coli was accompanied by relaxation and VIP release but not by NO production. Neither VIP release nor relaxation was affected by L-NNA. In isolated muscle cells of tenia coli, VIP caused relaxation but did not stimulate NO production; relaxation in these cells was not affected by L-NNA. We conclude that 1) VIP is the primary relaxant transmitter in both gastric muscle and tenia coli, 2) the release of VIP in gastric muscle but not in tenia coli stimulates NO production from target muscle cells, and 3) NO amplifies the relaxant effect of VIP in muscle cells and acts presynaptically to enhance the release of VIP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566853     DOI: 10.1152/ajpgi.1992.262.4.G774

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  69 in total

Review 1.  Targets of enteric motor neurones: smooth muscle cells.

Authors:  R K Goyal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

Review 2.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Basal release of nitric oxide induces an oscillatory motor pattern in canine colon.

Authors:  K D Keef; D C Murray; K M Sanders; T K Smith
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

4.  Inhibitory effect of schisandrin on spontaneous contraction of isolated rat colon.

Authors:  Jiaming Yang; Paul S P Ip; John H K Yeung; Chun-Tao Che
Journal:  Phytomedicine       Date:  2011-04-21       Impact factor: 5.340

5.  Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission.

Authors:  H Mashimo; X D He; P L Huang; M C Fishman; R K Goyal
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

6.  Colonic electrical stimulation regulates colonic transit via the nitrergic pathway in rats.

Authors:  Shi Liu; J D Z Chen
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

Review 7.  Regulation of basal tone, relaxation and contraction of the lower oesophageal sphincter. Relevance to drug discovery for oesophageal disorders.

Authors:  R Farré; D Sifrim
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 8.  Nitric oxide as a modulator of intestinal water and electrolyte transport.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

9.  Impairment of nitrergic-mediated relaxation of rat isolated duodenum by experimental diabetes.

Authors:  M A Martinez-Cuesta; H Massuda; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.

Authors:  Y M Qian; R L Jones
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.